Experts shared the key data that stood out in GU oncology at the 2026 ASCO Annual Meeting.
Related to this article
The top 5 OncLive TV videos of the week cover insights in bladder cancer, chronic myeloid leukemia, multiple myeloma, pancreatic cancer, and chronic lymphocytic leukemia.
Laure-Anne Teuwen, MD, PhD, debates the real-world advantages of subcutaneous pembrolizumab.
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
Experts shared the key data that stood out in hematologic oncology at the 2026 ASCO Annual Meeting.
In case you missed any, check out our recap of the episodes of OncLive On Air that aired in June 2026.
Hematologic oncology experts outline the top data and themes to emerge from the 2026 EHA Congress
The FDA approved a bioequivalent formulation of olaparib for use in previously approved cancer indications.
Advertisement
Advertisement
Trending on OncLive
1
Experts Revisit the Most Notable Data in GU Oncology From ASCO 2026
2
EO2463-Induced CD8 T-Cell Expansion Correlates With Survival Outcomes in Indolent NHL
3
Dr Mou on the Significance of Efficacy Data for Tacabrutideg in CLL
4
HR-Positive/HER2-Negative Early Breast Cancer: Emerging Endocrine Strategies and the Potential Role of Giredestrant
5